Keyword: Breakthrough Therapy Designation (BTD)
News
19.02.2016
- Major drug makers Roche and AstraZeneca have been granted breakthrough therapy designations (BTD) by the US Food and Drug Administration (FDA) for treatments in multiple sclerosis...
News
01.02.2016
- The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to UK-Swedish drug maker AstraZeneca for its oral poly ADP-ribose polymerase (PARP)...
